HopeStageGet research updates
HopeStage
hi@hopestage.com

Built by people with lived experience, between Sydney and Paris.

Back to all studies
CompletedNCT05282329

Efficacy of tACS for Treatment of Auditory Hallucinations in Refractory Schizophrenia

Device studyAges 18–70China
The study in practice

Understand this study

Who was this study for?

Listed age limits: 18 years to 70 years.

Listed locations
Tianjin, ChinaSee all locations and recruitment
Activities
Device procedures described in the protocol · Sham comparator
Compensation
Payment and expense reimbursement have not been verified.
Study clarity

Study information

Study start dateStarted: September 1, 2020
Recruitment status
Completed
Enrollment listed in the registry
50
Sponsor
Tianjin Anding Hospital
Sponsor type
Hospital / academic medical center
Study type
Device
Intervention type
DEVICE
Study phase
Not clearly listed
Locations
China
Age range
From 18 Years to 70 Years
Official registry ID
NCT05282329
Official title
Show the full official title

Efficacy of Transcranial Alternating Current Stimulation (tACS) as an Add-on Treatment for Auditory Hallucinations in Refractory Schizophrenia: A Randomized, Double-blind, Sham-controlled Trial

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Tianjin

Checked Official study record (opens in a new tab)
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Tianjin Anding Hospital, a hospital or academic medical center.

Who was this study for?

Listed age limits: 18 years to 70 years.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me
Related studies

Explore related studies

Other studies that may be relevant based on condition, country, or study type.